Quality control in clinical chemistry: characterization of reference materials.

[1]  J. Bohner,et al.  Determination of creatine kinase MB activity with the Du Pont aca: interferences from the sample matrix. , 1984, Clinical chemistry.

[2]  Desire L. Massart,et al.  The Interpretation of Analytical Chemical Data by the Use of Cluster Analysis , 1983 .

[3]  M. D. O'donnell,et al.  Suitability of control materials in the differential inhibition assay for human pancreatic and salivary amylase. , 1983, Clinical chemistry.

[4]  P. Broughton,et al.  The Seralzyer and use of quality-control materials. , 1983, Clinical chemistry.

[5]  R. Jansen.  Comparison of Routine Analytical Methods in the Netherlands for Seven Serum Constituents Using Pattern Recognition , 1983, Annals of clinical biochemistry.

[6]  H. Wieland,et al.  Improved assessment of plasma lipoprotein patterns. IV. Simple preparation of a lyophilized control serum containing intact human plasma lipoproteins. , 1982, Clinical chemistry.

[7]  A. Louderback,et al.  Stabilized liquid control sera for creatine kinase isoenzymes. , 1982, Clinical chemistry.

[8]  R. W. Jenny,et al.  Measurement of alkaline phosphatase activity: characterization and identification of an inactivator in 2-amino-2-methyl-1-propanol. , 1981, Clinical Chemistry.

[9]  L. Kricka,et al.  Matrix effects in clinical analysis: commutability of control materials between the Ektachem, Beckman and SMA 12/60 glucose and urea methods. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[10]  D. Miller,et al.  Fluorescence polarization immunoassay. II. Analyzer for rapid, precise measurement of fluorescence polarization with use of disposable cuvettes. , 1981, Clinical chemistry.

[11]  A. Vassault,et al.  Suitability of control materials for determination of alpha-amylase activity. , 1981, Clinical chemistry.

[12]  J P Bretaudiere,et al.  Suitability of control materials. General principles and methods of investigation. , 1981, Clinical chemistry.

[13]  E. Sampson,et al.  Characterization and intermethod relationships of materials containing purified human pancreatic and salivary amylase. , 1981, Clinical chemistry.

[14]  D. Bonderman,et al.  An optically clear hypercholesterolemic hypertriglyceridemic quality-control material prepared from animal lipid sources. , 1981, Clinical chemistry.

[15]  L. Kricka,et al.  Characterisation of the protein matrix of quality control sera by a high resolution two-dimensional electrophoresis technique. , 1980, Clinica chimica acta; international journal of clinical chemistry.

[16]  M. Pergande,et al.  Suitability of commercial control sera for the quality control of activity determination of alkaline phosphatase. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[17]  J. Souverijn,et al.  Comparison of intermethod analytical variability of patient sera and commercial quality control sera. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[18]  C. Fraser,et al.  Evaluation of Precision Using Lyophilised Quality Control Materials , 1978, Annals of clinical biochemistry.

[19]  R. Rej.  Effect of incubation with Mg2+ on the measurement of alkaline phosphatase activity. , 1977, Clinical chemistry.

[20]  E. Egger,et al.  Suitability of commercial enzyme control sera for the quality control of activity determinations of L-aspartate aminotransferase and L-alanine aminotransferase in human serum. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[21]  J. Rosenbusch,et al.  Determination of the Donnan effect in equilibrium dialysis and a simple method for its correction. , 1977, Analytical biochemistry.

[22]  C. Reimer,et al.  Standardization of human immunoglobulin quantitation: a review of current status and problems. , 1976, Clinical chemistry.

[23]  W. Miller,et al.  On the design of clinical chemistry quality-control sera. , 1976, Clinical chemistry.

[24]  D. Bonderman,et al.  Preparation of optically clear lyophilized human serum for use in preparing control material. , 1976, Clinical chemistry.

[25]  B. Steele,et al.  An example of lyophilized protein-based materials not simulating patient sera. , 1975, Clinical chemistry.

[26]  R. Rej,et al.  Interlaboratory proficiency, intermethod comparison, and calibrator suitability in assay of serum aspartate aminotransferase activity. , 1975, Clinical chemistry.

[27]  Shin-Ho Chung.  Structure of the cerebellum , 1974, Nature.

[28]  R. Rej,et al.  Assay of aspartate aminotransferase activity: effects of serum and serum proteins on oxalacetate decarboxylation and dialysis. , 1974, Clinical chemistry.

[29]  R. Rej,et al.  An L-aspartate: 2-oxoglutarate aminotransferase reference material from human erythrocytes: preparation and characterization. , 1972, Clinical Chemistry.

[30]  C. Price,et al.  An improved autoanalyzer technique for the determination of serum alkaline phosphatase. , 1971, Clinica chimica acta; international journal of clinical chemistry.

[31]  I. Sunshine,et al.  Determination of glutethimide (Doriden) and its metabolites in biologic specimens. , 1968, Clinical chemistry.

[32]  R. Elin,et al.  Liquid and lyophilized quality-control materials compared for use in continuous-flow analysis. , 1984, Clinical chemistry.

[33]  D. Fast,et al.  Development of a reference material for alkaline phosphatase. , 1984, Clinical chemistry.

[34]  J. Philcox,et al.  Preparation and Characterization of a Human Serum Matrix Suitable for Quality Control or Reference Materials , 1983, Pathology (Sydney).

[35]  B. Tabachnick,et al.  Using Multivariate Statistics , 1983 .

[36]  J. Albers,et al.  Evaluation of quality-control materials for high-density-lipoprotein cholesterol quantitation. , 1981, Clinical chemistry.

[37]  W. Frajola,et al.  A stable liquid human reference serum. , 1976, Health laboratory science.